Citations

Clear

3942 citation(s) found for "To, Van".

What's New in Olfactory Neuroblastoma: Updated Literature Review through the 2024 NASBS Annual Meeting
Liu, Lauren , Trent, Monica , Choby, Garret, Geltzeiler, Mathew, Gunn, Brandon, Lechner, Matt, Gompel, J. Van, Gompel, Jamie J. Van , Van Gompel, Jamie J , Choby, Garret , Geltzeiler, Mathew , Lechner, Matt , Kuan, Edward C

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | February 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1055/a-2805-9694 Get It

Abstract This review aims to update recent advancements in the management and treatment of olfactory neuroblastoma (ONB) based on discussions and topics highlighted during the 2024 North American Skull Base Society session “Literature Review: What's New in Olfactory Neuroblastoma?” A systematic review was conducted using PubMed/MEDLINE, focusing on relevant studies published between January 2022 and June 2024. Data were organized into themes: prognostication and staging, surgical concepts, biomarkers/genomics, imaging, syndrome of inappropriate antidiuretic hormone release and hyponatremia, chemotherapy, and radiotherapy. Out of 289 initial records, 46 studies met eligibility criteria. Key findings include the proposed integration of Hyams grading and dural infiltration with traditional staging for better prognostic accuracy, a shift toward less invasive surgical techniques while maintaining clear resection margins, and the identification of biomarkers for improved diagnosis and targeted therapy. Advanced imaging modalities like DOTA-peptide tomography (positron emission tomography–computed tomography/magnetic resonance imaging) were highlighted for their diagnostic value. Variability in induction chemotherapy outcomes underscores the need for personalized treatment plans, and new radiotherapy techniques offer promising results with improving morbidity. Recent advancements in ONB management have enhanced prognostic accuracy, molecular diagnostics, imaging techniques, and treatment outcomes. Continuous research is necessary to optimize these strategies and further improve patient survival and quality of life.
Artificial intelligence–based quantification of breast arterial calcifications to predict cardiovascular morbidity and mortality
Dapamede, Theo , Khan, Aisha Urooj , Joshi, Vedant , Gershon, Gabrielle , Li, Frank , Chavoshi, Mohammadreza , Brown-Mulry, Beatrice , Isaac, Rohan , Mansuri, Aawez , Robichaux, Chad , Sperling, Laurence , O’Neill, W Charles , Dapamede, Theodorus , Urooj, Aisha , Isaac, Rohan Satya , Ayoub, Chadi , Arsanjani, Reza , Sperling, Laurence , Gichoya, Judy W. , van Assen, Marly , O'Neill, W Charles , Banerjee, Imon , Trivedi, Hari , Arsanjani, Reza , Gichoya, Judy Wawira , Assen, Marly van , Banerjee, Imon , Trivedi, Hari

Mayo Clinic

European Heart Journal | February 10, 2026 | Volume: 47 | Issue: 18 | Pages: 2206-2220

10.1093/eurheartj/ehag128 | PMID 41795899 Get It

Abstract Background and Aims Women are underdiagnosed and undertreated for cardiovascular disease (CVD). Automatic quantification of breast arterial calcification (BAC) on screening mammography can identify women at risk for CVD. This study aimed to determine whether artificial intelligence–based automatic quantification of BAC from screening mammograms predicts CVD and mortality beyond PREVENT scores in a large, racially diverse, multi-institutional population. Methods This retrospective cohort study included 123 762 women from two healthcare systems who had screening mammograms. Breast arterial calcification was quantified using a transformer-based neural network for segmentation. Breast arterial calcification severity was categorized as zero (0 mm2), mild (>0–10 mm2), moderate (>10–25 mm2), and severe (>25 mm2). Kaplan–Meier analysis, Cox proportional hazards, and Fine–Gray competing event models were used to examine the association between BAC and major adverse cardiovascular events (MACE). Results Breast arterial calcification was detected in 16.1% (internal cohort) and 20.6% (external cohort) of women and provided significant prognostic value incremental to the PREVENT score. In PREVENT adjusted models, a clear dose–response was observed. Compared with zero BAC, mild [internal: hazard ratio (HR) 1.32, 95% confidence interval (CI) 1.10–1.59; external: HR 1.28, 95% CI 1.17–1.39], moderate (internal: HR 1.75, 95% CI 1.23–2.50; external: HR 1.79, 95% CI 1.55–2.06), and severe BAC (internal: HR 3.29, 95% CI 2.15–5.05; external: HR 2.80, 95% CI 2.36–3.32) were all prognostic for any MACE. Each 1 mm2 increase in BAC conferred an additional 2%–3% risk for MACE (P < .001). Conclusions Automatically quantified BAC is an independent predictor of MACE and mortality, adding prognostic value to the PREVENT score. This approach may provide an opportunistic cardiovascular risk assessment during routine mammography screening without additional radiation exposure to guide earlier and more effective preventive care for women.
Videographic Analysis of an Intervention to Improve Patient-Centered Care for People Living with Type 2 Diabetes: the QBSAFE Randomized Trial
Montori, J P, Larios, Felipe , Bandi, Satya Sai Sri, Proano, Ana Cristina , Guevara, Kerly , Vilatuna, Luis , Bagewadi, Shubhangi , Gastel, Anka Van, Branda, Megan E. , Camp, Anne, Montosa, Mel, Larios, Felipe , Montori, Victor , Bandi, Satya Sri , Van Gastel, Anka , Branda, Megan , McCoy, Rozalina Grubina , Montori, Victor M , Lipska, Kasia J , Montori, Víctor M. , Andrango, Luis Vilatuna, McCoy, Rozalina G., Lipska, Kasia J.

Mayo Clinic

No container title available | February 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.02.06.26345767 | PMID 41728336 Get It

Abstract Background The self-management of type 2 diabetes (T2D) typically requires enacting various lifestyle changes, which can challenge people living with T2D. Clinical encounters between people with T2D and their clinicians, however, are often focused on metabolic management, leaving less time available for other self-management topics. The QBSAFE cards help patients articulate aspects of their experience with diabetes and prioritize issues for discussion. Methods This report details secondary outcomes of a randomized controlled trial; primary outcomes are reported elsewhere. All data was collected at Fair Haven Community Health Care, a federally qualified primary care clinic. 11 clinicians were randomly assigned to provide either usual care or usual care with QBSAFE cards to 155 of their patients with type 2 diabetes and hemoglobin A1c >8%. All patient encounters were video recorded for analysis. Patients and clinicians were not blinded to arm allocation but were kept unaware of the specific aims of the trial. Encounter video reviewers were blinded to arm allocation, but not to specific aims of the trial. The outcomes of interest for this report were the extent to which the QBSAFE cards were used as intended, their effect on the topics of discussion, and whether they enabled clinicians to notice and respond to each patient’s situation; comparisons between arms were conducted by a linear mixed model with fixed effect of arm and cluster effect of clinician, analyzed in both intent-to-treat and per-protocol populations. Findings 12 patients were excluded post-randomization (A1c <8%). Of 143 eligible patients, 137 encounters (65 in the usual care arm, 72 in QBSAFE) yielded evaluable videos. QBSAFE was used as intended in 61 (85%) QBSAFE arm encounters. Conversations about burden of treatment related to non-pharmacological interventions (17 vs 33, p = 0·04) and taking medications (11 vs 33, p = 0·0008) and about the patient’s challenging environment (2 vs 10, p = 0·04) were more prevalent in the QBSAFE group. There was no difference in the rate of conversations about metabolic management or of new care plans as a result of conversations between groups. Interpretation While there was a difference in the types of conversations observed between the two study arms, this difference was small and only apparent in a few domains. Future work could aim to modify the QBSAFE cards to more effectively stimulate patient-centered discussions and to further prepare clinicians to respond to a variety of issues raised during the clinical visit. Funding This work was supported by funding from the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK129616).
Editorial. The computer is always watching: artificial intelligence–powered analysis of operating room turnover
Gompel, Jamie J Van, Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurosurgery | February 7, 2026 | Volume: 144 | Issue: 5 | Pages: 1233-1234

10.3171/2025.10.jns252359 | PMID 41650450 Get It

Picture living with diabetes: A photovoice study of young adults' efforts in making diabetes care fit into their lives
Gastel, Anka Van, Graner‐Baars, Matthijs, Koning, Eelco J.P. de , Tran, V., Dinneen, Sean R. , Mesman, Jessica, Swaak, Joris, Aanstoot, Henk‐Jan, Stiggelbout, Anne, Kunneman, Marleen, Mesman, Jessica , Van Gastel, Anka , De Koning, Eelco J P , Dinneen, Sean F , Kunneman, Marleen , Graner, Matthijs, Montori, Víctor M. , Tran, Viet-Thi , Aanstoot, Henk‐Jan , Kunneman, Marleen

Mayo Clinic

Diabetic Medicine | February 6, 2026 | Volume: 43 | Issue: 5 | Pages: No page available

10.1111/dme.70246 | PMID 41645388 Get It

Abstract Aim This study aimed to identify what young adults with type 1 diabetes (T1D) do to make diabetes care fit in their lives and the impact of diabetes and diabetes care on living. Methods Dutch young adults with T1D (18–30 years old) submitted photographed real‐life situations of efforts to make care fit and of the impact of care on their lives. Participants organised their photos in themes, which guided the focus group discussions. We added a reflective questionnaire, semi‐structured interview and iterative validation to identify participant‐defined themes and summarise the data. Results Participants ( N = 18) submitted 240 photographs in total, showing a broad range of situations and emotions. Participants identified 16 themes, grouped into four overarching categories describing their experiences with diabetes: (1) My diabetes: glucose levels, workload, 24/7 present; (2) My life: flow of (daily) life, special and irregular circumstances, life changes, body and health; (3) Support: devices and technology, social network, clinical (diabetes) care; (4) Mental aspects: emotional processes, perspective, being a patient. In the overlap of My diabetes and My life, they identified eating and counting carbohydrates, activity and exercise, recreational substances. Conclusion Young adults with T1D face the complex challenge of fitting their care into their ever‐changing lives. While support systems, such as devices, healthcare professionals and social networks can help, they can also create burdens. Participants emphasised the importance of mental health in their lives with T1D. This study highlights the need for diabetes care that acknowledges the emotional, social and practical realities of young adults' lives.
Prenatal Closure of Myeloschisis vs Myelomeningocele: Insights From the fMMC Consortium Registry
Hersh, David S. , Anuar, Amirul, Anadkat, Jagruti , Bennett, Kelly, Blumenfeld, Yair J. , Buchanan, Christopher Q., Clifford, Caitlin , Emery, Stephen P. , Gebb, Juliana , Goodnight, William H. , Herzeg, Akos , Heuer, Gregory G. , Hirose, Shinjiro , Jampa, Alekhya , Lillegard, Joseph B. , Lim, Foong-Yen, Luks, François I. , Moehrlen, Ueli, Moldenhauer, Julie S. , Cortes, M. Sanz, Schenone, Mauro H., Wagner, Amy J., Zaretsky, Michael V. , Crombleholme, Timothy M., Anadkat, Jagruti , Goodnight, William , Gebb, Juliana S , Moehrlen, Ueli , Cortes, Magdalena Sanz , Schenone, Mauro H , Tsao, KuoJen , Van Mieghem, Tim , Zaretsky, Michael V , Crombleholme, Timothy M , Lim, Foong‐Yen Y. , Miller, Jena L. , Shaaban, Aimen F.

Mayo Clinic

Neurosurgery | February 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1227/neu.0000000000003954 | PMID 41642007 Get It

BACKGROUND AND OBJECTIVES: Myelomeningocele is defined by the presence of a fluid-filled sac that contains the neural placode and cerebrospinal fluid (CSF) at the level of the spinal defect. Alternatively, the term myeloschisis is used when the neural placode is not contained within a CSF-filled sac. While both are eligible for prenatal closure, few studies have characterized the impact of the type of lesion on postnatal outcomes. This study compares the outcomes of these 2 types of open spinal dysraphism using data from the Fetal Myelomeningocele Consortium registry sponsored by the North American Fetal Therapy Network. METHODS: The prospective observational Fetal Myelomeningocele Consortium registry was used to extract deidentified data corresponding to patients who underwent fetal closure of myelomeningocele vs myeloschisis. Demographics, operative characteristics, perioperative complications, and postnatal outcomes were collected. RESULTS: A total of 1327 patients were identified, including 991 (74.7%) with myelomeningocele and 336 (25.3%) with myeloschisis. Compared with myelomeningocele, myeloschisis was associated with lower rates of prenatal talipes (11% vs 24%, P < .001) and higher rates of favorable prenatal movement (94% vs 86%, P < .001). Postnatally, myeloschisis conferred higher rates of leg movement (97% vs 90%, P = .002) and an increased likelihood of ambulation in the household (10.4% vs 4.1%, P = .009) and outside (7.2% vs 1.9%, P = .004) at 1 year. However, myeloschisis was also linked to greater use of skin patches during closure (49% vs 27%, P < .001), higher CSF leak rates among those with wound dehiscence (26% vs 8%, P = .014), and more frequent CSF diversion and tethered cord surgeries at follow-up. CONCLUSION: Myeloschisis and myelomeningocele demonstrate distinct clinical profiles. Although patients with myeloschisis may have favorable motor outcomes, they are also characterized by higher rates of CSF leakage, CSF diversion, and tethered cord surgery. These findings highlight the need for lesion-specific prognostication and may inform surgical planning and parental counseling in the context of prenatal spina bifida closure.
Optimization of pre-test probability models for obstructive coronary artery disease using explainable artificial intelligence
Hennecken, Jasper, Verpalen, V A, Vijver, W R Van De, Planken, R N, Somsen, G A, Tulevski, I I, Claessen, B E P M, Winter, M M, Verpalen, Victor A. , van de Vijver, Willem R , Planken, R. Nils , Somsen, G A, Tulevski, Igor I. , Claessen, B.E.P.M., Winter, Michiel M.

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.186 Get It

Abstract Background Computed tomography coronary angiography (CCTA) has emerged as a powerful non-invasive imaging modality for the evaluation of coronary artery disease (CAD), with a global trend towards a "CT-first" strategy in stable patients with suspected CAD. While overall beneficial, this approach requires a shift in resources, straining specific parts of healthcare systems. Pre-test probability (PTP) models stratify risks of obstructive CAD and are intended to result in better utilization of CCTA. However, these models show variability across subpopulations and have modest discriminatory power with low positive predictive values (PPV). Purpose This study aims to leverage explainable artificial intelligence (XAI) for optimization of PTP models. Methods Patients that underwent a CCTA for suspected CAD with a CAD-Reporting and Data System (CAD-RADS) classification and Coronary Artery Calcium Score (CACS) were included. Obstructive CAD was defined as stenosis &gt;50% (CAD-RADS 3 or higher). Missing data was imputed. The Risk Factor Weighted Clinical Likelihood (RF-CL) model based on clinical risk factors (age, sex, type of symptoms, smoking, hypertension, dyslipidemia, diabetes and familial predisposition) was calculated. Two gradient descent-based decision tree models, "AI-ECG" and "AI-CAC" were developed. AI-ECG is built using clinical risk factors and electrocardiogram (ECG) classification. AI-CAC is built using the aforementioned features with addition of CACS. Sensitivity analysis was performed using a 15% threshold, aligning with the threshold for CCTA acquisition. Comparative analysis was performed using Python 3.10.2, with area under the curve (AUC) analysis using the DeLong test and feature importance calculation using shapely values. Preliminary results: We identified 6178 patients with a CCTA between 2022 and 2024 in the Cardiology Centers Netherlands (CCN) and included 2083 patients (mean age 57.4 ± 10.2; 48.1% male). Obstructive CAD was present in 413 (19.8%) patients. The RF-CL model was outperformed by the AI-ECG model (AUC: 0.69 vs 0.80, p&lt;0.001) and the AI-CACS model (AUC: 0.69 vs 0.90, p&lt;0.001). Although sensitivity increased in both the AI-ECG and AI-CACS models from 0.46 to 0.87 and 0.83 respectively, PPV increased only in the AI-CACS model (0.37 to 0.61). Most important features were CACS, age, sex, ECG classification and familial predisposition. Conclusion and Discussion Our study demonstrates that the incorporation of XAI with clinical risk factors, ECG classification and CACS improves the pre-test probability estimation of obstructive CAD. ECG classification appears to be a robust feature. Adopting these models can stratify patients at risk for obstructive CAD, enabling targeted use of CCTA, reducing unnecessary testing, and thus alleviate the burden on healthcare systems. However, further external validation is necessary to assess the model’s performance in prospective real-world settings.Sensitivity analysis feature importance
Low myocardial extracellular volume is associated with increased QRS voltages and false positives in ECG-based left ventricular hypertrophy classification in elite athletes
Diepen, M A Van, Daems, J J N, Verwijs, S M, Hattum, J C Van, Boekholdt, S M, Randen, Adriënne van , Planken, R N, Postema, P G, Kors, J A, Bijsterveld, N R, Moen, M H, Asselbergs, F W, Wilde, A A M, Jorstad, H T, Asselbergs, Folkert W. , Diepen, Maarten A. van , Daems, Joëlle J N , Verwijs, S M, Hattum, Juliette C. van , Boekholdt, S. Matthijs , Planken, R. Nils , Postema, Pieter G. , Kors, Jan A. , Zwaard, Stephan van der , Bijsterveld, Nick R. , Moen, MH, Wilde, Arthur A.M. , Jorstad, H T

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.3957 Get It

Abstract Background Increased QRS voltages in athletes’ ECGs are attributed to electrophysiological cellular adaptations, complicating the detection of left ventricular hypertrophy (LVH). Conversely, higher extracellular volume (ECV), indicative of diffuse fibrosis, reduces QRS voltages – so-called ‘relative voltage deficiency’– and can mask true LVH on ECG. Purpose To investigate sex-specific associations between QRS voltages and myocardial ECV and assess the impact of ECV on false-positive and negative ECG-LVH detection in elite athletes. Methods We conducted a cross-sectional, sex-specific, contrast-enhanced CMR study in healthy, elite athletes with normal ECGs and no complete right bundle branch blocks. Myocardial ECV (%) was measured from pre- and post-contrast T1 mapping. LVH on CMR was defined as an indexed LVM &gt;75 g/m² (men) or &gt;59 g/m² (women). Primary analyses evaluated correlations between ECV, LVM, and summed 12-lead ECG voltages (including voltage/LVM to assess independence), as well as Sokolow-Lyon and Cornell voltages. Secondary multivariable logistic regression examined the association of ECV on false-positive and false-negative ECG-LVH rates using Sokolow-Lyon (≥3.5 mV) and sex-specific Cornell (≥2.8 mV in men; ≥2.3 mV in women) criteria for CMR-LVH. Results In 162 elite athletes (median age 25 years, 44% female, 45% endurance, 96% Caucasian), 23% met Sokolow-Lyon criteria, 6% met Cornell criteria, and 17% had LVH on CMR. The median myocardial ECV was 23% (range 19–31%), which was lower in male compared to female athletes (22% [Q1-Q3: 21–23%] vs 25% [23–26%]; p&lt;0.001). In both sexes, summed 12-lead voltages were inversely correlated with ECV (ρ=–0.36 to –0.37; p=0.001), independent of LVM (voltage/LVM: ρ=–0.33; p=0.004). Only in female athletes did 12-lead voltages correlate with LVM (ρ=0.37; p=0.001). Logistic regression confirmed that lower ECV was associated with an increased likelihood of false-positive Sokolow-Lyon (OR: 0.64 per 1% ECV increment; p=0.011), independent of body mass index (OR: 0.77 per kg/m²; p=0.039) male sex (OR: 2.7; p=0.123) and age (OR: 0.93 per year; p=0.075; AUROC 0.82). Higher ECV conferred greater odds of a false-negative (OR 3.98 per %; p=0.041), though this was limited by small LVH-positive sample size. In Cornell-based models, lower ECV was not statistically significantly associated with increased false-positive rate (OR 0.59; p=0.059). Conclusion In elite athletes, lower ECV ("denser" myocardium) is associated with increased QRS voltages and higher false-positive ECG-LVH rate, particularly for Sokolow-Lyon, while higher ECV may dampen voltages and can mask true LVH on the ECG. Although sex-specific criteria partly mitigate ECV-related effects, these findings demonstrate inherent limitations of voltage-based LVH criteria in athletes. Unexpectedly low QRS voltages in athletes with otherwise high LVM may imply increased ECV, though further research is warranted.Figure:Likelihood of False Pos SL rate Table:Population characteristics
Evaluation of coronary plaque burden in type 2 diabetes: insights from a propensity-matched CCTA study
Vijver, W R Van De, Verpalen, V A, Hennecken, Jasper, Tulevski, I I, Somsen, G A, Planken, R N, Claessen, B E P M, Winter, M M, van de Vijver, Willem R , Verpalen, Victor A. , Tulevski, Igor I. , Planken, R. Nils , Claessen, B.E.P.M., Winter, M M

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.2041 Get It

Abstract Background Coronary Computed Tomography Angiography (CCTA) is the first-line diagnostic tool for suspected stable Coronary Artery Disease (CAD) to rule out obstructive CAD and is recommended for risk stratification. Both obstructive CAD and total plaque burden on CCTA predict cardiovascular (CV) risk. Prior studies demonstrated that type 2 diabetes (T2D) patients exhibit greater plaque burden and higher CV event risk. Purpose This study evaluates whether T2D patients undergoing CCTA for stable CAD symptoms, when matched for traditional cardiovascular risk factors, have a higher prevalence of CAD and greater atherosclerotic plaque burden. Methods A total of 568 patients were included: 284 T2D patients were 1:1 propensity-matched to 284 non-T2D patients based on age, sex, and CV risk factors. All underwent diagnostic CCTA between January 2022 and November 2023. CCTA parameters included CAD-Reporting and Data System (RADS) classification, segment involvement score (SIS), coronary artery calcium (CAC) score, and plaque composition. SIS was defined as the number of segments with at least mild plaque. Coronary segmentation followed the 16-segment model (SCCT). Plaque burden was classified as P1 (mild), P2 (moderate), P3 (severe), and P4 (extensive) per CAD-RADS 2.0, based on SIS, CAC score, and the number and severity of affected vessels. Results The mean age was 60.8 ± 9.97 years (T2D) vs. 61.2 ± 9.80 years (non-T2D), with similar gender distribution (48.6% vs. 48.9% female). BMI was significantly higher in T2D patients (29.2 vs. 26.5, p &lt; 0.05). Smoking was less frequent in T2D patients (56.0% vs. 60.9%, p = 0.03). Other CV risk factors were similar. T2D patients were more likely to use antiplatelet and lipid-lowering agents. CAD prevalence was higher in T2D patients (83.1% vs. 76.4%, p &lt; 0.05), while obstructive CAD was not significantly higher in T2D (33.5% vs. 27.5%, p = 0.13). No significant differences were observed in 1-, 2-, or 3-vessel disease. The SIS was significantly higher in T2D patients (3.85 vs. 3.37, p = 0.03). CAC scores were higher in T2D patients (median 60 [6–369] vs. 31 [0–224]), though not statistically significant. For plaque burden classification, P2 (moderate plaque burden) was more common in non-T2D patients (23.6% vs. 15.5%, p = 0.02), while P4 (extensive plaque burden) was significantly higher in T2D patients (21.1% vs. 14.1%, p = 0.03). Conclusion When matched for cardiovascular risk factors, T2D patients more frequently exhibited CAD on CCTA, with higher SIS scores and a greater prevalence of extensive plaque burden (P4 classification). Despite greater use of preventive medication and a lower smoking prevalence in the T2D group, plaque burden remained higher in these patients. These findings emphasize the need for improved risk stratification and preventive strategies in individuals with T2D.
The value of hybrid functional and anatomical imaging for guiding revascularization decision-making by the heart team in patients with prior coronary artery bypass grafting
Hoek, R, Winter, R W De, Planken, N R, Somsen, Y B O, Jukema, R A, Raijmakers, P G, Twisk, J W R, Diemen, P A Van, Driessen, R S, Danad, Ibrahim , Delewi, R, Nap, A, Knaapen, Paul, Hoek, Roel , Planken, R. Nils , Somsen, Yvemarie , Jukema, Ruurt , Raijmakers, Pieter G.H.M. , Diemen, PA Van, Driessen, R S, Delewi, Ronak , Nap, Alexander , Knaapen, Paul

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.3293 Get It

Abstract Background Coronary computed tomography angiography (CCTA) and myocardial perfusion imaging (MPI) are guideline-recommended to assist in clinical decision-making in patients with prior coronary artery bypass grafting (CABG). However, the value of combining CCTA and MPI for guiding revascularization decision-making in post-CABG patients with recurrent ischemic symptoms remains unexplored. In this study, we compared Heart Team strategies for revascularization based on CCTA and MPI as standalone and hybrid CCTA/MPI imaging, to strategies guided by invasive coronary angiography (ICA). Methods We included symptomatic patients with prior CABG who underwent CCTA and MPI (single-photon emission computed tomography, positron emission tomography or stress perfusion cardiac magnetic resonance imaging) preceding ICA. Simulated Heart Teams, blinded to other Heart teams and outcomes, performed revascularization decision-making based on conventional CCTA, MPI and a hybrid CCTA/MPI strategy (non-invasive Heart Team) or based on ICA (invasive Heart Team). The primary outcome was the Cohen’s kappa agreement (κ) between non-invasive and invasive Heart Teams. Results A total of 115 patients (mean age 73±7 years; 99 [86%] male) were included. Revascularization was recommended in 96 patients (83.5%) by CCTA, 92 patients (80.0%) by MPI, 80 patients (69.6%) by hybrid CCTA/MPI and 76 patients (66.1%) by ICA. The agreements were significant but low for CCTA (κ: 0.25 [95% confidence interval (CI): 0.07-0.42], P=0.003) and MPI (κ: 0.27 [95% CI: 0.09-0.48], P=0.002) compared to ICA, with only a modest increase when using the hybrid non-invasive imaging strategy (κ: 0.32 [95% CI: 0.14-0.51], P&lt;0.001). Conclusions In patients with recurrent ischemic symptoms after CABG, Heart Team assessment of conventional CCTA and MPI yielded similarly poor agreements with revascularization strategies based on ICA, with only a modest improvement observed when using a hybrid CCTA/MPI approach. Overall, non-invasive imaging alone appears insufficient to accurately guide treatment strategies in patients with prior CABG, and their use as gatekeeping for ICA in these patients should be questioned.